Glaucoma Market Research Report and Trends Forecasts 2017 to 2021 Glaucoma Market Global Analysis 2017 | Page 2

Glaucoma Industry Global Market Analysis, Growth, Share, Industry Trends
and Forecasts to 2021
“Global Glaucoma Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this
market, with focus on the US and OUS treatment market. The major trends, growth drivers as well as issues
being faced by the market are discussed in detail in this report. The four major players: Pfizer Inc., Novartis
AG, Merck & Co., Inc. and Allergan Plc. are being profiled along with their key financials and strategies for
growth. The report contains a comprehensive analysis of the global glaucoma market along with the study
of the US market.
Company Coverage of Global Glaucoma Market: Pfizer Inc., Novartis AG, Merck & Co Inc., and Allergan Plc.
Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss. The most
common type is open-angle glaucoma with less common types including closed-angle glaucoma and
normal-tension glaucoma. Open-angle glaucoma develops slowly over time and there is no pain. Side vision
may begin to decrease followed by central vision resulting in blindness, if not treated. Closed-angle
glaucoma can present gradually or suddenly. The sudden presentation may involve severe eye pain, blurred
vision, mid-dilated pupil, redness of the eye, and nausea. Vision loss from glaucoma, once it has occurred,
is permanent.
Complete report available at http://www.marketreportsonline.com/591783.html